Search

Search Constraints

You searched for: Author/Creator Ye, Xu

Search Results

3. A Large‐Scale Multicenter Study Validates Aldo‐Keto Reductase Family 1 Member B10 as a Prevalent Serum Marker for Detection of Hepatocellular Carcinoma. Issue 6 (6th April 2019)

5. Bendamustine in the treatment of patients with indolent non‐Hodgkin lymphoma refractory or relapse to rituximab treatment: An open‐label, single‐agent, multicenter study in China. Issue 4 (21st December 2022)